FINAXIONResearch
Finaxion Research · Supertrend: the line that changes colour · single stocks · Recomputed 2026-09-10

Does Supertrend: the line that changes colour work on FFIV?

Supertrend: the line that changes colour does not beat buy-and-hold on FFIV: -6.6 points a year over 27 years.

Total return
×11
Buy and hold
×55
CAGR
9.2%
Sharpe
0.33
Max drawdown
-93.2%
Trades
45
Out of sample
partly
Years
27
1×10×20002002200420062008201020122014201620182020202220242026
StrategyFFIV

Findings

  1. Supertrend: the line that changes colour does not beat buy-and-hold on FFIV: -6.6 points a year over 27 years.
  2. Against the S&P 500 over the same window: +0.7 points a year.
  3. Total return ×11 versus ×55 for buy-and-hold, with 45 trades.
  4. The result holds only partly out of sample.
  5. Maximum drawdown -93.2%.
  6. It beats in neither half of the history (split at 2013).
  7. It ranks #55 of 235 markets for this strategy by annual excess over the S&P 500.

Findings derived from the full panel. Each carries its number and its denominator; the computations are reproducible with artifact e097c9613211.

Exactly what was tested

Entry when the close exceeds the upper band (ATR 10, multiplier 3); exit when the close drops below the lower band. The classic Supertrend definition.

How to read it

The verdict compares the strategy with buying and holding FFIV over the same window, with round-trip costs per asset class. “Out of sample” is walk-forward: the rule is fit on one stretch and judged on the next. A result that beats in the full sample but not out of it is overfit. Full methodology in the protocol. How we test.

Open this backtest with its trades   Trades (CSV)

Every strategy on FFIV → · Full page for Supertrend: the line that changes colour →

How to cite

Finaxion Research (2026). Does Supertrend: the line that changes colour work on FFIV?. Daily backtest 1962-01-01–2026-08-31, artifact e097c9613211. https://finaxion.app/en/research/supertrend/ffiv

Not a recommendation. Past performance does not guarantee future results.